The global market for migraine drugs has been growing at a healthy pace and is likely to exhibit a promising growth rate in the coming few years. The rising cases of migraine and the rapid development of the healthcare infrastructure in emerging economies are estimated to support the overall growth of the global migraine drugs market in the next few years.
As per the market research study by Transparency Market Research, in 2016, the global market for migraine drugs stood at US$2.72 bn and is projected to reach US$3.72 bn by 2025.

Source: Click here